The average one-year price target for Clinuvel Pharmaceuticals (OTC:CLVLF) has been revised to 18.70 / share. This is an increase of 12.19% from the prior estimate of 16.67 dated October 12, 2022. The price target is an average of many targets provided by analThe average one-year price target for Clinuvel Pharmaceuticals (OTC:CLVLF) has been revised to 18.70 / share. This is an increase of 12.19% from the prior estimate of 16.67 dated October 12, 2022. The price target is an average of many targets provided by anal
